Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10085672 | 0.86 | — | — | |
| SCHEMBL15280937 | 0.81 | PTGER4 (0.32) | PKMSMN1; SMN2 | |
| SCHEMBL15979464 | 0.81 | PTGER4 (0.32) | PKMSMN1; SMN2 | |
| SCHEMBL21359651 | 0.79 | RORA (0.31) | — | |
| SCHEMBL10028822 | 0.75 | LMNA (0.33) | — | |
| SCHEMBL15790118 | 0.71 | TP53 (0.38) | HPGDSMN1; SMN2 | |
| SCHEMBL13449890 | 0.71 | — | — | |
| SCHEMBL19342530 | 0.71 | PKM (0.31) | PKMSMN1; SMN2 | |
| SCHEMBL793562 | 0.70 | ALDH1A1 (0.32) | — | |
| SCHEMBL20783505 | 0.69 | TNF (0.34) | USP2POLBPKMHPGDKEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2435497-B1 | POLYCYCLIC DITHIOPHENES | CLAP CO LTD (KR) | 2023-07-05 | — | — | EP | disclosed |
| US-9716241-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2017-07-25 | — | — | US | disclosed |
| US-9716241-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2017-07-25 | — | — | US | disclosed |
| US-20160104849-A1 | POLYCYCLIC DITHIOPHENES | BASF SE (DE) | 2016-04-14 | — | — | US | disclosed |
| US-20160104849-A1 | POLYCYCLIC DITHIOPHENES | BASF SE (DE) | 2016-04-14 | — | — | US | disclosed |
| US-9233930-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2016-01-12 | — | — | US | disclosed |
| US-9233930-B2 | Polycyclic dithiophenes | BASF SE (DE) | 2016-01-12 | — | — | US | disclosed |
| US-20120097935-A1 | POLYCYCLIC DITHIOPHENES | BASF SE (DE) | 2012-04-26 | — | — | US | disclosed |
| WO-2010136401-A2 | POLYCYCLIC DITHIOPHENES | BASF SE (DE) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160104849-A1 | POLYCYCLIC DITHIOPHENES | C1R, C2CD5, CBR3 | USP2 3631/4885POLB 4746/4885PKM 3621/4885 |
| US-20120097935-A1 | POLYCYCLIC DITHIOPHENES | C1R, IPO5, C2CD5 | USP2 4661/4885POLB 4762/4885PKM 3312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.